Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?

References

1. Al-Doory Y. An immune factor in baboon anti-candida serum. Sabouraudia 1970; 8:41–47
   [Google Scholar]
2. Ashman R.B., Papadimitriou J.M. Murine candidiasis: strain dependence of host responses after immunization. Immunol Cell Biol 1988; 66:231–237
   [Google Scholar]
3. Ashman R.B., Papadimitriou J.M. Strain dependence of antibody-mediated protection in murine systemic candidiasis. J Infect Dis (letter) 1993; 168:511–513
   [Google Scholar]
4. Borg M., Ruchel R. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J Med Vet Mycol 1990; 28:3–14
   [Google Scholar]
5. Burnie J.P. Candida and hands. J Hosp Infect 1986; 8:1–4
   [Google Scholar]
6. Burnie J.P., Odds F.C., Lee W., Webster C., Williams J.D. Outbreak of systemic Candida albicans in intensive care unit caused by cross-infection. Br Med J 1985; 290:746–748
   [Google Scholar]
7. Burnie J.P., Matthews R.C., Lee W., Philpott-Howard J., Brown R., Damani N., Breuer J., Honeywell K., Jordans Z. Four outbreaks of nosocomial systemic candidiasis. Epidemiol Infect 1987; 99:201–211
   [Google Scholar]
8. Calderone R.A., Lineham L., Wadsworth E., Sandberg A.L. Identification of C3d receptors of Candida albicans. Infect Immun 1988; 56:252–258
   [Google Scholar]
9. Cohen I.R. The cognitive paradigm and the immunological homunculus. Immunol Todaj 1992; 13:490–494
   [Google Scholar]
10. Cutler J.A. Acute systemic candidiasis in normal and congenitally thymid-deficient (nude) mice. J Reticuloendothel Soc 1976; 19:121–124
    [Google Scholar]
11. De Repentigny L., Reiss E. Current trends in immuno-diagnosis of candidosis and aspergillosis. Rep Infect Dis 1984; 6:301–312
    [Google Scholar]
12. Douglas L.J. Adhesion of Candida species to epithelial surfaces. CRC Crit Rev Microbiol 1987; 15:27–43
    [Google Scholar]
13. Douglas L.J. Mannoprotein adhesins of Candida albicans. In New Strategies in Fungal Disease 1992 Edited by Bennett J.E., Hay R.J., Peterson P.K. Edinburgh: Churchill Livingstone; pp 34–50
    [Google Scholar]
14. Dupont B., Improvisi L., Ronin O., Provost F. Clinical impact of antifungal drug resistance in AIDS patients 1994 Abstract no. S14·4 ISHAM. Adelaide, Australia
    [Google Scholar]
15. Edison A.M., Manning-Zweerink M. Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent. Infect Immun 1988; 56:1388–1390
    [Google Scholar]
16. Edwards J.E. Invasive Candida infections. Evolution of a fungal pathogen [editorial]. New Engl J Med 1991; 324:1060–1062
    [Google Scholar]
17. Edwards J.E. Human complement receptor-like molecules on Candida. In New Strategies in Fungal Disease 1992 Edited by Bennett J.E., Hay R.J., Peterson P.K. Edinburgh: Churchill Livingstone; pp 54–62
    [Google Scholar]
18. Edwards I.E., Gaither T.A. Jr, O'Shea J.J., Rotrosen D., Lawley T.J., Wright S.A., Frank M.M., Green I. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol 1986; 137:3577–3583
    [Google Scholar]
19. Gething M.-J., Sambrook J. Protein folding in the cell. Nature 1992; 355:33–45
    [Google Scholar]
20. Giger D.J., Domer J., Moser S., McQuitty J. Experimental murine candidiasis: pathological and immune responses in T lymphocyte depleted mice. Infect Immun 1978; 21:729–737
    [Google Scholar]
21. Gilmore B.J., Retsinas E.M., Lorenz J.S., Hostetter M.K. An iC3b receptor of Candida albicans structure, function and correlates for pathogenicity. J Infect Dis 1993; 157:38–46
    [Google Scholar]
22. Heidenreich F., Dierich M.P. Candida albicans and Candida stellatoidea in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect Immun 1985; 50:598–600
    [Google Scholar]
23. Hube B., Turver C.J., Odds F.C., Eiffert H., Boulnois G., Kdchel H., Riichel R. Sequences of the Candida albicans gene encoding the secretory aspartate proteinase. J Med Vet Mjcol 1991; 29:129–131
    [Google Scholar]
24. Hube B., Monod M., Schofield D.A., Brown A.J.P., Gow N.A.R. Differential regulation of six genes encoding secretory aspartyl proteinase in Candida albicans 1994 Abstract no. P04. 6, ISHAM. Adelaide, Australia
    [Google Scholar]
25. Kang A.S., Barbas C.F., Janda K.D., Benkovic S.J., Lerner R.A. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci USA 1991; 88:4363–4366
    [Google Scholar]
26. Kaufmann S.H.E. Heat shock proteins and the immune response. Immunol Today 1990; 11:129–136
    [Google Scholar]
27. King R.D., Lee J.C., Morris A.L. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect Immun 1980; 27:667–674
    [Google Scholar]
28. Komshian S.V., Uwaydah A.K., Sobel J.D., Crane L.R. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient. Rev Infect Dis 1989; 11:379–390
    [Google Scholar]
29. Kwong-Chung K.J., Lehman D., Good C., Magee P.T. Genetic evidence for the role of extracellular proteinase in virulence of Candida albicans. Infect Immun 1985; 49:571–576
    [Google Scholar]
30. Linehan L., Wadsworth E., Calderone R. Candida albicans C3d receptor, isolated by using a monoclonal antibody. Infect Immun 1988; 56:1981–1986
    [Google Scholar]
31. Macdonald F. Secretion of inducible proteinase by pathogenic Candida species. Sabouraudia 1984; 22:79–82
    [Google Scholar]
32. Macdonald F., Odds F.C. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol 1980; 13:423–435
    [Google Scholar]
33. Macdonald F., Odds F.C. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol 1983; 129:431–438
    [Google Scholar]
34. Maiti P.K., Kumar A., Kumar R., Mohapatra L.N. Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice. Mjcopatbologia 1985; 91:79–86
    [Google Scholar]
35. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. By -passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222:581–597
    [Google Scholar]
36. Marquis G., Montplaisir S., Pelletier M., Mousseau A., Auger P. Strain-dependent differences in susceptibility of mice to experimental candidosis. J Infect Dis 1986; 154:906–909
    [Google Scholar]
37. Matthews R.C. HSP 90, yeasts and Corynebacteriumjeikeium. Epidemiol Infect 1991; 107:273–283
    [Google Scholar]
38. Matthews R.C. Early diagnosis of systemic candidal infection. J Antimicrob Chemother 1993; 31:809–812
    [Google Scholar]
39. Matthews R.C. Recent advances in antibody engineering. Serodiag Immunother Infect Dis 1994 (in press);
    [Google Scholar]
40. Matthews R.C., Burnie J.P. Diagnosis of systemic candidosis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47 kDa antigen. J Clin Microbiol 1988; 26:459–463
    [Google Scholar]
41. Matthews R.C., Burnie J.P. Cloning of a DNA sequence encoding a major fragment of the 47 kilodalton stress protein homologue of Candida albicans. FEMS Microbiol Lett 1989; 60:25–30
    [Google Scholar]
42. Matthews R.C., Burnie J.P. The role of hsp 90 in fungal infection. Immunol Today 1992; 13:345–348
    [Google Scholar]
43. Matthews R.C., Burnie J.P., Tabaqchali S. Immunoblot analysis of the serological response in systemic candidosis. Lancet 1984; 11:1415–1418
    [Google Scholar]
44. Matthews R.C., Burnie I.P., Tabaqchali S. Isolation of immunodominant antigens from the sera of patients with systemic candidosis and characterization of the serological response to Candida albicans. J Clin Microbiol 1987; 25:230–237
    [Google Scholar]
45. Matthews R.C., Burnie J.P., Smith D., Clark I., Midgley J., Conolly M., Gazzard B. Candida and AIDS: evidence for protective antibody. Lancet 1988; 11:263–266
    [Google Scholar]
46. Matthews R.C., Burnie J.P., Howat D., Rowland T., Walton F. Autoantibody to HSP 90 can mediate protection against systemic candidosis. Immunology 1991a; 74:20–24
    [Google Scholar]
47. Matthews R.C., Burnie J.P., Lee W. The application of epitope mapping to the development of a new serological test for systemic candidosis. J Immunol Methods 1991b; 143:73–79
    [Google Scholar]
48. Mourad S., Friedman L. Passive immunisation of mice against Candida albicans. Sabouraudia 1968; 6:103–105
    [Google Scholar]
49. Neale T.J., Muir J.C., Drake B. The immunochemical characterisation of circulating immune complex constituents in Candida albicans osteomyelitis by isoelectric focusing, immunoblot, and immunoprint. Aust NZ J Med 1987; 17:201–209
    [Google Scholar]
50. Pearsall N.N., Adams P.L., Bunni R. Immunologic responses to Candida albicans. III. Effect of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol 1978; 120:1176–1180
    [Google Scholar]
51. Ray T.L., Payne C.D. Role of Candida acid proteinase in adhesion and invasion of murine epidermis 1994 Abstract no. S5·5, ISHAM. Adelaide Australia
    [Google Scholar]
52. Rogers T.J., Balish E., Manning D.D. The role of thymus dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc 1976; 20:291–298
    [Google Scholar]
53. Ross I.K., De Bernadis F., Emerson G.W., Cassone A., Sullivan P.A. The secreted aspartate proteinase of Candida albicans-, physiology of secretion and virulence of a proteinase-deficient mutant. J Gen Microbiol 1990; 136:687–694
    [Google Scholar]
54. Rotrosen D., Calderone R.A., Edwards J.E. Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 1986; 8:73–85
    [Google Scholar]
55. Ruchel R. Properties of a purified proteinase from the yeast Candida albicans. Biochim Biophys Acta 1981; 659:99–113
    [Google Scholar]
56. Ruchel R., Boning-Stutzer B., Mari A. A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data. Mycoses 1988; 31:87–106
    [Google Scholar]
57. Ruchei R., Ritter B., Schaffrinski M. Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentrabl Bakteriol 1990; 273:391–403
    [Google Scholar]
58. Rustchenko-Bulgac E.P., Howard D.H. Multiple chromosomal and phenotypic changes in spontaneous mutants of Candida albicans. J Gen Microbiol 1993; 139:1195–1207
    [Google Scholar]
59. Sasada M., Johnston R.B. Macrophage microbicidal activity. Correlation between phagocytosis-associated metabolism and killing of Candida by macrophages. J Exp Med 1980; 152:85–98
    [Google Scholar]
60. Schwartz J.A., Mizukami H. A metal-linked gapped zipper model is proposed for the 90 kDa heat shock protein-estrogen-receptor interface. Med Hypotheses 1991; 35:140–145
    [Google Scholar]
61. Slutsky B., Staebell M., Anderson J., Risen L., Pfaller M., Soli D.R. 'white-opaque transition': a second high-frequency switching system in Candida albicans. J Bacteriol 1987; 169:189–197
    [Google Scholar]
62. Soderland E., Simonsson A.C., Borrebaeck C.A.K. Phage display technology in antibody engineering: design of phagemid vectors and in vitro maturation systems. Immunol Rev 1992109–124
    [Google Scholar]
63. Soli D.R. Switching and its possible role in Candida pathogenesis. In New Strategies in Fungal Disease 1992 Edited by Bennett J.E., Hay R.J., Peterson P.K. Edinburgh: Churchill Livingstone; pp 156–172
    [Google Scholar]
64. Soil D.R., Galask R., Isley S., Rao T.V.G., Stone D., Hicks J., Schmid J., Mac K., Hanna C. Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol 1989; 27:681–690
    [Google Scholar]
65. Sugar A.M. Candidiasis in AIDS patients 1994 Abstract no. S3·1, ISHAM. Adelaide, Australia
    [Google Scholar]
66. Sullivan W.P., Toft D.O. Mutational analysis of hsp 90 binding to the progesterone receptor. J Biol Chem 1993; 268:20373–20379
    [Google Scholar]
67. Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988; 148:642–2645
    [Google Scholar]
68. Winter G., Harris W.J. Humanized antibodies. Immunol Today 1993; 14:243–246
    [Google Scholar]
69. Young D.B. Heat shock proteins -immunity and autoimmunity. Curr Opin Immunol 1992; 4:396–400
    [Google Scholar]